FDA Drug Application (061806) for CLOXAPEN by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number061806
Product Number001
FormCAPSULE;ORAL
DosageEQ 250MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCLOXAPEN
Active IngredientCLOXACILLIN SODIUM

Active IngredientCount
List of drugs with Active Ingredient CLOXACILLIN SODIUM3


Back to FDA Applications sponsored by GLAXOSMITHKLINE